ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,490 Cr | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,490 Cr |
| Mar2024 | ₹2,609 Cr |
| Mar2023 | ₹521 Cr |
| Mar2022 | ₹283 Cr |
| Mar2021 | ₹235 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,490 Cr | -42.91 | |
| Mar2024 | ₹2,609 Cr | 400.58 | |
| Mar2023 | ₹521 Cr | 83.94 | |
| Mar2022 | ₹283 Cr | 20.34 | |
| Mar2021 | ₹235 Cr | - | |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹20,115.0 Cr | 0.1% | 2.9% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 0.1% |
2.9% |
-14.4% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses